- Home
- TIL vs LNKB Comparison
TIL vs LNKB Comparison
Compare TIL & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- LNKB
- Stock Information
- Founded
- TIL 2018
- LNKB 2018
- Country
- TIL United States
- LNKB United States
- Employees
- TIL N/A
- LNKB N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- TIL Health Care
- LNKB
- Exchange
- TIL Nasdaq
- LNKB Nasdaq
- Market Cap
- TIL 230.1M
- LNKB 256.4M
- IPO Year
- TIL 2021
- LNKB N/A
- Fundamental
- Price
- TIL $23.14
- LNKB $7.48
- Analyst Decision
- TIL Buy
- LNKB Strong Buy
- Analyst Count
- TIL 5
- LNKB 1
- Target Price
- TIL $119.00
- LNKB $9.00
- AVG Volume (30 Days)
- TIL 387.8K
- LNKB 62.6K
- Earning Date
- TIL 08-12-2025
- LNKB 07-28-2025
- Dividend Yield
- TIL N/A
- LNKB 4.11%
- EPS Growth
- TIL N/A
- LNKB N/A
- EPS
- TIL N/A
- LNKB 0.97
- Revenue
- TIL N/A
- LNKB $120,786,000.00
- Revenue This Year
- TIL N/A
- LNKB $21.23
- Revenue Next Year
- TIL N/A
- LNKB N/A
- P/E Ratio
- TIL N/A
- LNKB $7.54
- Revenue Growth
- TIL N/A
- LNKB 135.60
- 52 Week Low
- TIL $9.62
- LNKB $6.00
- 52 Week High
- TIL $92.00
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- TIL 43.15
- LNKB 58.73
- Support Level
- TIL $21.29
- LNKB $6.67
- Resistance Level
- TIL $31.67
- LNKB $7.09
- Average True Range (ATR)
- TIL 3.95
- LNKB 0.21
- MACD
- TIL -1.71
- LNKB 0.02
- Stochastic Oscillator
- TIL 8.60
- LNKB 97.06
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.